Statistical support for HIV nonvaccine biomedical prevention product development
Ended Awarded Last action
- Contract number
- HHSN27200004
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $206,491
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2015029 Solicitation number
- Comprehensive Resources for HIV Microbicides and Biomedical Prevention Award Notice · Posted Jun 24, 2015
- Contract value 14% obligated
-
- $206,490.80 Current, with exercised options
- $1,529,440.80 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $8,744 | |
| Original award | $197,747 |
About this award
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $1,529,440.80 cost-plus-fixed-fee contract provides statistical support for HIV non-vaccine biomedical prevention product development under NIAID's "Comprehensive Resources for HIV Microbicides and Biomedical Prevention" program. The contract does not have a set-aside designation. ABL holds several Indefinite Delivery Vehicles (IDVs) with NIAID and other NIH institutes, demonstrating its broad capabilities in biopharmaceutical research and development to support the advancement of vaccines, therapeutics, and diagnostics across various disease areas.
Quick answers
Who was awarded contract HHSN27200004?
HHSN27200004 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 12, 2016.
How much is contract HHSN27200004 worth?
The government has obligated $206,491 on HHSN27200004. Its potential value, with all options, is $1,529,441.
Is contract HHSN27200004 an order under another contract?
Yes. HHSN27200004 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract HHSN27200004 competed?
The extent of competition for HHSN27200004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award